Skip to main content

Ibere Pharmaceuticals (IBER)

NYSE: IBER · IEX Real-Time Price · USD
9.71 0.01 (0.10%)
Oct 21, 2021 4:00 PM EDT - Market closed
Market Cap167.32M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out13.80M
EPS (ttm)n/a
PE Ration/a
Forward PEn/a
Ex-Dividend Daten/a
Previous Close9.70
Day's Range9.71 - 9.71
52-Week Range9.60 - 9.95
Price Targetn/a
Est. Earnings Daten/a

About IBER

Ibere Pharmaceuticals focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in Philadelphia, Pennsylvania.

IndustryBlank Check / SPAC
IPO DateFeb 26, 2021
Stock ExchangeNYSE
Ticker SymbolIBER
Full Company Profile


Ibere Pharmaceuticals Receives Expected NYSE Notice Regarding Delayed Quarterly Report

PHILADELPHIA, May 28, 2021 /PRNewswire/ -- Ibere Pharmaceuticals (NYSE: IBER) (the "Company") today announced that it received a notice on May 25, 2021 from the New York Stock Exchange (the "NYSE") indi...

4 months ago - PRNewsWire

Ibere Pharmaceuticals Announces Closing of $138,000,000 Initial Public Offering

Ibere Pharmaceuticals (the "Company") announced today that it closed its initial public offering of 13,800,000 units at $10.00 per unit, which...

7 months ago - PRNewswire

Private equity manager's SPAC Ibere Pharmaceuticals files for a $100 million IPO

Ibere Pharmaceuticals, a blank check company formed by PIPV Capital targeting pharmaceutical or life science businesses, filed on Tuesday with the SEC to raise up to $100 million in an initial public of...

8 months ago - NASDAQ

Ibere Pharmaceuticals IPO Registration Document (S-1)

Ibere Pharmaceuticals has filed to go public with an IPO on the New York Stock Exchange (NYSE).

8 months ago - SEC